← Browse by Condition
Medical Condition

relapsed small cell lung cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT06128837 Phase 3
Recruiting

Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer

Enrollment
686 pts
Location
China
Sponsor
Luye Pharma Group Ltd.
View Trial →